Synaptogenix, Inc. (SNPX)

NASDAQ: SNPX · IEX Real-Time Price · USD
0.201
+0.003 (1.52%)
Mar 28, 2024, 11:04 AM EDT - Market open

Total Valuation

Synaptogenix has a market cap or net worth of $3.92 million. The enterprise value is -$27.81 million.

Market Cap 3.92M
Enterprise Value -27.81M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

Synaptogenix has 20.39 million shares outstanding. The number of shares has increased by 53.16% in one year.

Shares Outstanding 20.39M
Shares Change (YoY) +53.16%
Shares Change (QoQ) +45.39%
Owned by Insiders (%) 3.24%
Owned by Institutions (%) 5.20%
Float 19.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.15
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.79, with zero debt.

Current Ratio 17.79
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -28.30% and return on invested capital (ROIC) is -45.14%.

Return on Equity (ROE) -28.30%
Return on Assets (ROA) -23.20%
Return on Capital (ROIC) -45.14%
Revenue Per Employee n/a
Profits Per Employee -$1.64M
Employee Count 5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.05% in the last 52 weeks. The beta is 1.61, so Synaptogenix's price volatility has been higher than the market average.

Beta (1Y) 1.61
52-Week Price Change -77.05%
50-Day Moving Average 0.20
200-Day Moving Average 0.41
Relative Strength Index (RSI) 48.52
Average Volume (30 Days) 801,298

Short Selling Information

The latest short interest is 426,593, so 2.09% of the outstanding shares have been sold short.

Short Interest 426,593
Short Previous Month 540,327
Short % of Shares Out 2.09%
Short % of Float 2.16%
Short Ratio (days to cover) 0.37

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -12.07M
Pretax Income -560,190
Net Income -8.18M
EBITDA -553,527
EBIT -560,190
Earnings Per Share (EPS) -$1.05
Full Income Statement

Balance Sheet

The company has $31.73 million in cash and no debt, giving a net cash position of $31.73 million or $1.56 per share.

Cash & Cash Equivalents 31.73M
Total Debt n/a
Net Cash 31.73M
Net Cash Per Share $1.56
Equity / Book Value 26.74M
Book Value Per Share 1.31
Working Capital 30.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.89 million and capital expenditures -$4,846, giving a free cash flow of -$6.90 million.

Operating Cash Flow -6.89M
Capital Expenditures -4,846
Free Cash Flow -6.90M
FCF Per Share -$0.64
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Synaptogenix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -53.16%
Shareholder Yield -53.16%
Earnings Yield -209.02%
FCF Yield -176.13%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on May 19, 2021. It was a reverse split with a ratio of 1:4.

Last Split Date May 19, 2021
Split Type Reverse
Split Ratio 1:4

Scores

Altman Z-Score n/a
Piotroski F-Score 1